{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:35:50Z","timestamp":1779244550977,"version":"3.51.4"},"reference-count":191,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanghai Hospital Development Center Foundation","award":["SHDC22022303"],"award-info":[{"award-number":["SHDC22022303"]}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-Level Local Universities in Shanghai","doi-asserted-by":"crossref","award":["SHSMU-ZDCX20212200"],"award-info":[{"award-number":["SHSMU-ZDCX20212200"]}],"id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Joint Funds of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U24A20658"],"award-info":[{"award-number":["U24A20658"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2703002"],"award-info":[{"award-number":["2022YFC2703002"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Female fertility preservation (FFP) has become a clinical priority because gonadotoxic therapies for cancer and benign diseases are increasingly common and may cause irreversible ovarian failure. The current clinical practice guideline provides evidence-based recommendations on fertility assessment, oocyte\/embryo cryopreservation, and ovarian tissue cryopreservation and transplantation for women at risk of iatrogenic infertility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This guideline was developed in accordance with the WHO Handbook for Guideline Development. A multidisciplinary Guideline Development Group (GDG) formulated nine key clinical questions in the field of FFP, and Cochrane-standard systematic reviews were conducted for each question. The certainty of the evidence was assessed using the GRADE approach, with critical outcomes including live birth, clinical pregnancy, time to pregnancy, treatment-related delays in oncotherapy, and severe ovarian hyperstimulation syndrome (OHSS). Recommendations were formulated by the GDG through the GRADE Evidence-to-Decision framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and discussion<\/jats:title>\n                    <jats:p>The GDG agreed on nine recommendations tailored to the Chinese clinical practice environment. When cancer treatment must start within two weeks, a random-start stimulation protocol is conditionally endorsed; pooled data show only one extra mature oocyte, but the time saved outweighs the marginal gonadotrophin increase. Letrozole co-administration is strongly recommended because it restrains oestradiol without reducing yield and may lessen OHSS risk in hormone-sensitive tumours. For ovarian tissue cryopreservation, slow freezing and vitrification are deemed equivalent in the absence of comparative trials; institutional capacity dictates the choice. Concurrent GnRH-agonist during chemotherapy is strongly advised across seventeen RCTs and improves subsequent live birth. Oocyte cryopreservation is weakly preferred to tissue for sexually mature women on the basis of higher cumulative pregnancy and lower morbidity, while ovarian tissue cryopreservation remains the default when stimulation is impossible. Baseline fertility evaluation should combine age, AMH and AFC; no single marker is superior, yet together they refine counselling. Orthotopic transplantation is strongly favoured over heterotopic grafting because published live births are almost exclusively pelvic. Finally, ovarian cortical fragments should undergo routine histopathology, augmented\u2014according to metastatic risk\u2014by immunohistochemistry, PCR or murine xenograft; tissue harbouring malignant cells is usually withheld from re-implantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1730617","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:32:18Z","timestamp":1770013938000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical practice guideline for female fertility preservation"],"prefix":"10.3389","volume":"12","author":[{"given":"Ningxia","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Ding","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine & Fertility Preservation Program, International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]},{"name":"Shanghai Key Laboratory of Embryo Original Disease","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingbo","family":"Cai","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital with Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ri-Cheng","family":"Chian","sequence":"additional","affiliation":[{"name":"Laboratory of Research and Development, ARSCI Biomedical Inc.","place":["Jiaxing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Deng","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichun","family":"Guan","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Jin","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Tongji Hospital, Tongji Medicine College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"La","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Xinjiang Medical University","place":["Urumqi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Lin","sequence":"additional","affiliation":[{"name":"Reproductive and Genetic Hospital of CITIC-Xiangya","place":["Changsha, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiufeng","family":"Ling","sequence":"additional","affiliation":[{"name":"Women\u2019s Hospital of Nanjing Medical University, Nanjing Women and Children\u2019s Healthcare Hospital","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijuan","family":"Lou","sequence":"additional","affiliation":[{"name":"Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiying","family":"Lu","sequence":"additional","affiliation":[{"name":"Hainan Women and Children\u2019s Medical Center","place":["Haikou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Lv","sequence":"additional","affiliation":[{"name":"Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, National Cancer Center\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuying","family":"Pei","sequence":"additional","affiliation":[{"name":"Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, School of Basic Medical Science, Ningxia Medical University","place":["Yinchuan, Ningxia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Quan","sequence":"additional","affiliation":[{"name":"Nanfang Hospital, Southern Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhen","family":"Shen","sequence":"additional","affiliation":[{"name":"Fujian Medical University Union Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minfang","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Reproductive Center, Dalian Women and Children\u2019s Medical Group","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuxia","family":"Wang","sequence":"additional","affiliation":[{"name":"Center of Reproductive Medicine, Shengjing Hospital of China Medical University","place":["Shenyang, Liaoning, China"]},{"name":"Shenyang Reproductive Health Clinical Medicine Research Center","place":["Shenyang, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangwu","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Center for Reproductive Medicine, The Fourth Affiliated Hospital of School of Medicine, Zhejiang University","place":["Yiwu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[{"name":"Hainan JingHua Fertility and Obstetrics Hospital","place":["Haikou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihai","family":"Xu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Zhejiang University School of Medicine","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanqing","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The General Hospital of Chinese PLA","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Yuan","sequence":"additional","affiliation":[{"name":"School of Nursing, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Women & Infants Hospital of Zhengzhou","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinhua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shuguang Hospital, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingxue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Sun Yat-sen Memorial Hospital, Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehong","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Lanzhou University","place":["Lanzhou, China, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Anhui Medical University","place":["Hefei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine & Fertility Preservation Program, International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]},{"name":"Shanghai Key Laboratory of Embryo Original Disease","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.fertnstert.2019.09.013","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"112","year":"2019","journal-title":"Fertil Steril"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10815-012-9791-1","article-title":"Fertility preservation in young women with breast cancer","volume":"29","author":"Klemp","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/bmt.2017.21","article-title":"State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29\u201330 September 2015","volume":"52","author":"Dalle","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1530\/EJE-13-0694","article-title":"Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence","volume":"170","author":"Vatanen","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"hoaa052","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.fertnstert.2017.05.024","article-title":"Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives","volume":"108","author":"Martinez","year":"2017","journal-title":"Fertil Steril"},{"key":"ref7","first-page":"383","article-title":"Chinese expert consensus on clinical practice of female fertility preservation","volume":"41","year":"2021","journal-title":"Chin J Reprod Contracep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"Grade guidelines: 15. Going from evidence to recommendation-determinants of a recommendation\u2019s direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"102080","DOI":"10.1016\/j.jogoh.2021.102080","article-title":"Ovarian stimulation for fertility preservation in women with cancer: a systematic review and meta-analysis comparing random and conventional starts","volume":"50","author":"Alexander","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s10815-016-0721-5","article-title":"Ovarian stimulation in the luteal phase: systematic review and meta-analysis","volume":"33","author":"Boots","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.rbmo.2021.08.003","article-title":"Fertility preservation for women with breast cancer before chemotherapy: a systematic review and meta-analysis","volume":"44","author":"Chen","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1016\/j.fertnstert.2022.08.672","article-title":"Random-start versus conventional ovarian hyperstimulation for fertility preservation in female cancer patients: a systematic review and meta-analysis","volume":"118","author":"Sonmezer","year":"2022","journal-title":"Fertil Steril"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/j.fertnstert.2018.07.529","article-title":"Random start versus conventional start controlled ovarian stimulation in women with cancer: comparing oocyte yield among fertility preservation cycles","volume":"110","author":"Alexander","year":"2018","journal-title":"Fertil Steril"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1007\/s43032-023-01175-2","article-title":"Controlled ovarian stimulation initiated at different phases of the menstrual cycle for fertility preservation in oncological patients: a retrospective study","volume":"30","author":"Baig","year":"2023","journal-title":"Reprod Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1016\/j.fertnstert.2015.07.838","article-title":"Comparison of random start controlled ovarian stimulation with standard start in letrozole gonadotropin cycles for fertility preservation in women with breast cancer","volume":"104","author":"Bedoschi","year":"2015","journal-title":"Fertil Steril"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.fertnstert.2019.07.241","article-title":"Emergency COS in oncofertility preservation","volume":"112","author":"Braham","year":"2019","journal-title":"Fertil Steril"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.fertnstert.2013.07.1992","article-title":"Effective method for emergency fertility preservation: random-start controlled ovarian stimulation","volume":"100","author":"Cakmak","year":"2013","journal-title":"Fertil Steril"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1016\/j.fertnstert.2014.07.561","article-title":"Random start controlled ovarian stimulation results in high oocyte developmental competence and embryo quality","volume":"102","author":"Cakmak","year":"2014","journal-title":"Fertil Steril"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1016\/j.fertnstert.2012.07.629","article-title":"Effective method for emergency fertility preservation: random-start controlled ovarian hyperstimulation","volume":"98","author":"Cakmak","year":"2012","journal-title":"Fertil Steril"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1016\/j.fertnstert.2019.07.418","article-title":"Ovarian stimulation in cancer patients: random versus conventional start","volume":"112","author":"Coscia","year":"2019","journal-title":"Fertil Steril"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humrep\/deac242","article-title":"IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients","volume":"38","author":"Esmaeilian","year":"2023","journal-title":"Hum Reprod"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"i327","DOI":"10.1093\/humrep\/29.Supplement_1.1","article-title":"Timing of ovarian stimulation in patients prior to chemo-or radiotherapy-an analysis of 674 stimulations","volume":"29","author":"Germeyer","year":"2014","journal-title":"Hum Reprod"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3760\/cma.j.cn101441-20220626-00276","article-title":"Clinical practice of fertility preservation in young unmarried breast cancer patients","volume":"43","author":"Guo","year":"2023","journal-title":"Chin J Reprod Contracep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s43032-020-00412-2","article-title":"Comparison of oocyte and embryo quality between random start and controlled ovarian stimulation cycles in cancer patients undergoing fertility preservation","volume":"28","author":"\u0130srafilova","year":"2021","journal-title":"Reprod Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"i372","DOI":"10.1093\/humrep\/33.Supplement_1.1","article-title":"Comparison of conventional and random start ovarian stimulation for fertility preservation in oncological patients","volume":"33","author":"Jancar","year":"2018","journal-title":"Hum Reprod"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jogoh.2018.11.003","article-title":"Luteal phase stimulation, the future of fertility preservation? Retrospective cohort study of luteal phase versus follicular phase stimulation","volume":"48","author":"Jochum","year":"2019","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3346\/jkms.2015.30.3.290","article-title":"Efficacy of random-start controlled ovarian stimulation in cancer patients","volume":"30","author":"Kim","year":"2015","journal-title":"J Korean Med Sci"},{"key":"ref30","first-page":"i373","article-title":"Comparison of ovarian reserve and ovarian response to hyperstimulation in women undergoing oocyte vitrification according to the type of malignancy","volume":"32","author":"Lefebvre","year":"2017","journal-title":"Hum Reprod"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/humrep\/deaa029","article-title":"Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer\u2014a prospective nationwide Swedish multicenter study","volume":"35","author":"Marklund","year":"2020","journal-title":"Hum Reprod"},{"key":"ref32","first-page":"i68","article-title":"Experience in random-start ovarian stimulation in cancer patients","volume":"35","author":"Martirosyan","year":"2020","journal-title":"Hum Reprod"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"i42","DOI":"10.1093\/humrep\/deab126.021","article-title":"Outcomes of random-start ovarian stimulation protocols as a possible evidence of the theory of antral follicles continuous recruitment","volume":"36","author":"Martirosyan","year":"2021","journal-title":"Hum Reprod"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.fertnstert.2017.10.029","article-title":"Long-term outcomes in cancer patients who did or did not pursue fertility preservation","volume":"109","author":"Moravek","year":"2018","journal-title":"Fertil Steril"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"262A","DOI":"10.1177\/1933719116641257","article-title":"Random-start in vitro fertilization protocols have equivalent outcomes to cycle-specific protocols, but may not shorten time to cancer treatment","volume":"23","author":"Moravek","year":"2016","journal-title":"Reprod Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/j.fertnstert.2016.07.389","article-title":"Fertility preservation (FP) does not adversely impact long-term cancer outcomes","volume":"106","author":"Moravek","year":"2016","journal-title":"Fertil Steril"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejogrb.2018.09.007","article-title":"Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: comparison of random start and early follicular phase stimulation\u2014cohort study","volume":"230","author":"Muteshi","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/09513590.2021.2006458","article-title":"Outcomes of ovarian stimulation in the follicular and luteal phases of the menstrual cycle in cancer patients","volume":"37","author":"Nazarenko","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/01443615.2021.1931067","article-title":"Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre","volume":"42","author":"Sahin","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"ref40","first-page":"116","article-title":"Ovarian stimulation for fertility preservation in cancer patients: a prospective study","volume-title":"Int J Fertil Steril","author":"Shahrokh Tehraninejad","year":"2014"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5468\/ogs.2018.61.2.242","article-title":"The serum estradiol\/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins","volume":"61","author":"Shim","year":"2018","journal-title":"Obstet Gynecol Sci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3109\/09513590.2015.1080237","article-title":"Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre","volume":"31","author":"Simi","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/jog.15535","article-title":"The effect of aromatase inhibitor on controlled ovarian stimulation for oocyte cryopreservation in adolescent and young cancer patients","volume":"49","author":"Suzuki","year":"2023","journal-title":"J Obstet Gynaecol Res"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/j.fertnstert.2018.07.522","article-title":"Random-start ovarian stimulation does not negatively impact egg yield\/quality and produces high quality embryos in cancer patients","volume":"110","author":"Wald","year":"2018","journal-title":"Fertil Steril"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/j.fertnstert.2022.08.664","article-title":"Random-start protocol is effective in oncofertility patients","volume":"118","author":"Yilmaz","year":"2022","journal-title":"Fertil Steril"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"574669","DOI":"10.3389\/fonc.2020.574669","article-title":"Efficacy and safety of controlled ovarian stimulation with or without letrozole co-administration for fertility preservation: a systematic review and meta-analysis","volume":"10","author":"Bonardi","year":"2020","journal-title":"Front Oncol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/humrep\/dex027","article-title":"The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review","volume":"32","author":"Rodgers","year":"2017","journal-title":"Hum Reprod"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/09513590.2018.1534950","article-title":"Effect of letrozole added to gonadotropins in controlled ovarian stimulation protocols on the yield and maturity of retrieved oocytes","volume":"35","author":"Ben-Haroush","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.rbmo.2012.02.020","article-title":"The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women","volume":"24","author":"Checa Vizca\u00edno","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.fertnstert.2012.01.093","article-title":"Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment","volume":"97","author":"Domingo","year":"2012","journal-title":"Fertil Steril"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.rbmo.2013.01.003","article-title":"Response to ovarian stimulation in patients facing gonadotoxic therapy","volume":"26","author":"Johnson","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/humrep\/dew355","article-title":"Response to ovarian stimulation is not impacted by a breast cancer diagnosis","volume":"32","author":"Quinn","year":"2017","journal-title":"Hum Reprod"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3109\/09513590.2013.819083","article-title":"Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?","volume":"29","author":"Revelli","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"100049","DOI":"10.1016\/j.eurox.2019.100049","article-title":"Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients","volume":"4","author":"Sonigo","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10815-022-02692-w","article-title":"Vitrification versus slow freezing of human ovarian tissue: a systematic review and meta-analysis of histological outcomes","volume":"40","author":"Behl","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"ref56","author":"Liu","year":"2021"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"8538","DOI":"10.1038\/s41598-017-09005-7","article-title":"Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and meta-analysis","volume":"7","author":"Shi","year":"2017","journal-title":"Sci Rep"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e4095","DOI":"10.1097\/MD.0000000000004095","article-title":"Comparison of vitrification and conventional slow freezing for cryopreservation of ovarian tissue with respect to the number of intact primordial follicles: a meta-analysis","volume":"95","author":"Zhou","year":"2016","journal-title":"Medicine"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.rbmo.2022.06.016","article-title":"Experience, and gynaecological and reproductive health follow-up of young adult women who have undergone ovarian tissue cryopreservation","volume":"45","author":"Lefton","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10815-020-02033-9","article-title":"Efficacy of assisted reproductive technology after ovarian tissue transplantation in a cohort of 11 patients with or without associated infertility factors","volume":"38","author":"Vatel","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/rmb2.12380","article-title":"Ovarian tissue grafting: lessons learnt from our experience with 55 grafts","volume":"20","author":"Rozen","year":"2021","journal-title":"Reprod Med Biol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1093\/humrep\/deab167","article-title":"Experience with transplantation of human cryopreserved ovarian tissue to a sub-peritoneal abdominal site","volume":"36","author":"Gook","year":"2021","journal-title":"Hum Reprod"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.fertnstert.2020.03.037","article-title":"Evaluation of ovarian tissue transplantation: results from three clinical centers","volume":"114","author":"Shapira","year":"2020","journal-title":"Fertil Steril"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.rbmo.2019.01.006","article-title":"Overnight ovarian tissue transportation for centralized cryobanking: a feasible option","volume":"38","author":"Liebenthron","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s10815-018-1315-1","article-title":"Cryopreservation and transplantation of ovarian tissue: results from one center in the USA","volume":"35","author":"Silber","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/TiT.1000242","article-title":"Pregnancy after orthotopic ovarian tissue transplantation using N-hexyl-2-cyanoacrylate as a tissue adhesive","volume":"10","author":"Fabregues","year":"2018","journal-title":"Trends Transplant"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.fertnstert.2017.11.018","article-title":"Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study","volume":"109","author":"Diaz-Garcia","year":"2018","journal-title":"Fertil Steril"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"94.e1","DOI":"10.1016\/j.ajog.2015.10.001","article-title":"First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix scaffold using robot-assisted minimally invasive surgery","volume":"214","author":"Oktay","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.fertnstert.2016.04.031","article-title":"Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria","volume":"106","author":"Meirow","year":"2016","journal-title":"Fertil Steril"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/14647273.2016.1151561","article-title":"Cryopreservation of ovarian tissue in pediatric patients undergoing sterilizing chemotherapy","volume":"19","author":"Chambon","year":"2016","journal-title":"Hum Fertil"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s12885-016-2584-7","article-title":"Optimizing the process of fertility preservation in pediatric female cancer patients\u2014a multidisciplinary program","volume":"16","author":"Ben-Aharon","year":"2016","journal-title":"BMC Cancer"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/humrep\/dew007","article-title":"Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy","volume":"31","author":"Abir","year":"2016","journal-title":"Hum Reprod"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/aogs.12700","article-title":"Autotransplantation of cryopreserved ovarian tissue after treatment for malignant disease\u2014the first Norwegian results","volume":"94","author":"Tanbo","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/humrep\/deu353","article-title":"Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency","volume":"30","author":"Suzuki","year":"2015","journal-title":"Hum Reprod"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.fertnstert.2014.10.045","article-title":"Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center","volume":"103","author":"Dittrich","year":"2015","journal-title":"Fertil Steril"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/bmt.2015.111","article-title":"Ovarian tissue cryopreservation in girls undergoing haematopoietic stem cell transplant: experience of a single centre","volume":"50","author":"Biasin","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.fertnstert.2014.07.122","article-title":"Ovarian performance, IVF results, pregnancies and live births indicate; fertility preservation using ovarian tissue harvesting and transplantation of thawed ovarian strips is effective","volume":"102","author":"Meirow","year":"2014","journal-title":"Fertil Steril"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/humrep\/deu158","article-title":"Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis","volume":"29","author":"Imbert","year":"2014","journal-title":"Hum Reprod"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.fertnstert.2008.10.006","article-title":"Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience","volume":"93","author":"Oktay","year":"2010","journal-title":"Fertil Steril"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/jnci\/djab213","article-title":"Long-term outcomes with pharmacological ovarian suppression during chemotherapy in premenopausal early breast cancer patients","volume":"114","author":"Lambertini","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"S342","DOI":"10.1016\/j.annonc.2020.08.067","article-title":"Goserelin for ovarian protection in premenopausal breast cancer patients receiving cyclophosphamide containing chemotherapy","volume":"31","author":"Khalaf","year":"2020","journal-title":"Ann Oncol"},{"key":"ref82","first-page":"5","article-title":"Effect of goserelin acetate sustained-release depo on ovarian function in patients with gynecologic oncology after chemotherapy","volume":"15","author":"Zhang","year":"2018","journal-title":"Med Innov China"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/annonc\/mdx184","article-title":"GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial","volume":"28","author":"Leonard","year":"2017","journal-title":"Ann Oncol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.3969\/j.issn.1006-5725.2017.14.029","article-title":"Goserelin protects ovarian function of premenopausal women with breast cancer","volume":"33","author":"Fang","year":"2017","journal-title":"J Pract Med"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1200\/JCO.2015.65.8864","article-title":"No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial","volume":"34","author":"Demeestere","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa1413204","article-title":"Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy","volume":"372","author":"Moore","year":"2015","journal-title":"N Engl J Med"},{"key":"ref87","first-page":"111","article-title":"Clinical application of GnRH analogues in influencing menstrual resumption in premenopausal breast cancer patients","volume":"22","author":"Sun","year":"2014","journal-title":"Chin J Trauma Disabil Med"},{"key":"ref88","first-page":"59","article-title":"Evaluation of the effect of GnRH agonist on menstrual reverse in breast cancer cases treated with cyclophosphamide","volume":"35","author":"Karimi-Zarchi","year":"2014","journal-title":"Eur J Gynaecol Oncol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3969\/j.issn.1008-5971.2014.05.078","article-title":"Study on the protective effect of gonadotropin-releasing hormone agonists on ovarian function in systemic lupus erythematosus patients undergoing chemotherapy","volume":"22","author":"He","year":"2014","journal-title":"Pract J Cardiac Cereb Pneumal Vasc Dis"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s12032-013-0667-8","article-title":"Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial","volume":"30","author":"Song","year":"2013","journal-title":"Med Oncol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/AOG.0b013e31827374e2","article-title":"Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial","volume":"121","author":"Elgindy","year":"2013","journal-title":"Obstet Gynecol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1200\/JCO.2011.34.6890","article-title":"Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer","volume":"30","author":"Munster","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10549-009-0313-5","article-title":"Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial","volume":"117","author":"Sverrisdottir","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/978-0-387-48998-8_761","article-title":"Effect of Zoladex administered before chemotherapy on menstruation of patients with breast cancer","volume":"35","author":"Li","year":"2008","journal-title":"Chin J Clin Oncol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/10245330600954072","article-title":"Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD)","volume":"12","author":"Giuseppe","year":"2007","journal-title":"Hematology"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1743-7563.2007.00089.x","article-title":"Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy","volume":"3","author":"Gilani","year":"2007","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061429","article-title":"Successful pregnancies, births, and children development following oocyte cryostorage in female cancer patients during 25 years of fertility preservation","volume":"14","author":"Porcu","year":"2022","journal-title":"Cancers"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1093\/humrep\/deac225","article-title":"Determinants of transplantation success with cryopreserved ovarian tissue: data from 196 women of the Fertiprotekt network","volume":"37","author":"Lotz","year":"2022","journal-title":"Hum Reprod"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1054123","DOI":"10.3389\/fendo.2022.1054123","article-title":"Why are they not coming back? A single-center follow-up study on oncological women oocyte\u2019s storing for fertility preservation","volume":"13","author":"Immediata","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"845051","DOI":"10.3389\/fendo.2022.845051","article-title":"The experience of fertility preservation in a single tertiary center in Korea","volume":"13","author":"Choi","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s10815-021-02168-3","article-title":"Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience","volume":"38","author":"Mayeur","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"hoaa064","DOI":"10.1093\/hropen\/hoaa064","article-title":"A multi-centre, retrospective case series of oocyte cryopreservation in unmarried women diagnosed with haematological malignancies","volume":"2021","author":"Kato","year":"2021","journal-title":"Hum Reprod Open"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12905-021-01343-z","article-title":"Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation","volume":"21","author":"Karavani","year":"2021","journal-title":"BMC Womens Health"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ygyno.2021.03.030","article-title":"Fertility preservation in women with malignant and borderline ovarian tumors: experience of the French ESGO-certified center and pregnancy-associated cancer network (CALG)","volume":"161","author":"Geoffron","year":"2021","journal-title":"Gynecol Oncol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.fertnstert.2021.06.012","article-title":"Fertility preservation in childhood and adolescent female tumor survivors","volume":"116","author":"Filippi","year":"2021","journal-title":"Fertil Steril"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.fertnstert.2021.03.008","article-title":"Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers","volume":"115","author":"Dolmans","year":"2021","journal-title":"Fertil Steril"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.rbmo.2020.01.009","article-title":"The safety and satisfaction of ovarian tissue cryopreservation in prepubertal and adolescent girls","volume":"40","author":"Lotz","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejogrb.2020.07.053","article-title":"Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours","volume":"253","author":"Khiat","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/aogs.13735","article-title":"Ovarian tissue cryopreservation: low usage rates and high live-birth rate after transplantation","volume":"99","author":"Hoekman","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.fertnstert.2020.03.035","article-title":"Reproductive outcomes after in vitro fertilization treatment in a cohort of Danish women transplanted with cryopreserved ovarian tissue","volume":"114","author":"Dueholm Hjorth","year":"2020","journal-title":"Fertil Steril"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1093\/humrep\/deaa193","article-title":"Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study","volume":"35","author":"Delattre","year":"2020","journal-title":"Hum Reprod"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5935\/1518-0557.20190089","article-title":"Cancer fertility preservation: a report from a Brazilian social program","volume":"24","author":"Berton","year":"2020","journal-title":"JBRA Assist Reprod"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/jayao.2019.0124","article-title":"Ovarian stimulation is safe and effective for patients with gynecologic cancer","volume":"9","author":"Akel","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3389\/fendo.2019.00600","article-title":"Oocyte cryopreservation in oncological patients: eighteen years experience of a tertiary care referral center","volume":"10","author":"Specchia","year":"2019","journal-title":"Front Endocrinol"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"e12944","DOI":"10.2196\/12944","article-title":"DATOR Group. Development of ovarian tissue autograft to restore ovarian function: protocol for a French multicenter cohort study","volume":"8","author":"Pretalli","year":"2019","journal-title":"JMIR Res Protoc"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.3324\/haematol.2018.211094","article-title":"Post-transplant outcome of ovarian tissue cryopreserved after chemotherapy in hematologic malignancies","volume":"104","author":"Poirot","year":"2019","journal-title":"Haematologica"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/annonc\/mdx639","article-title":"Reproductive potential and performance of fertility preservation strategies in Brca-mutated breast cancer patients","volume":"29","author":"Lambertini","year":"2018","journal-title":"Ann Oncol"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000478045","article-title":"A real-life analysis of reproductive outcome after fertility preservation in female cancer patients","volume":"83","author":"Hulsbosch","year":"2018","journal-title":"Gynecol Obstet Investig"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00404-017-4311-2","article-title":"Operative techniques and complications of extraction and transplantation of ovarian tissue: the Erlangen experience","volume":"295","author":"Beckmann","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/humrep\/dew165","article-title":"Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates","volume":"31","author":"Van Der Ven","year":"2016","journal-title":"Hum Reprod"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/aogs.12934","article-title":"Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries\u2014compilation of 20 years of multicenter experience","volume":"95","author":"Rodriguez-Wallberg","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1093\/humrep\/dev230","article-title":"Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark","volume":"30","author":"Jensen","year":"2015","journal-title":"Hum Reprod"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.fertnstert.2014.10.045","article-title":"Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center","volume":"103","author":"Dittrich","year":"2015","journal-title":"Fertil Steril"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.rbmo.2014.09.002","article-title":"Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer","volume":"29","author":"Martinez","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.fertnstert.2013.02.004","article-title":"Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications","volume":"99","author":"Garcia-Velasco","year":"2013","journal-title":"Fertil Steril"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10815-013-9952-x","article-title":"A review of 15 years of ovarian tissue bank activities","volume":"30","author":"Dolmans","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.2217\/fon.12.152","article-title":"Cryopreservation of ovarian tissue in breast cancer patients: 10 years of experience","volume":"8","author":"Fabbri","year":"2012","journal-title":"Future Oncol"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.fertnstert.2010.07.1080","article-title":"Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: the Danish experience","volume":"95","author":"Schmidt","year":"2011","journal-title":"Fertil Steril"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.rbmo.2010.01.012","article-title":"In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation","volume":"20","author":"Oktay","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1093\/humrep\/dei250","article-title":"Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation","volume":"20","author":"Schmidt","year":"2005","journal-title":"Hum Reprod"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"i383","DOI":"10.1093\/humrep\/33.Supplement_1.1","article-title":"Impact of breast cancer prognostic factors on the response to controlled ovarian stimulation in patients undergoing fertility preservation","volume":"33","author":"Zeghari","year":"2018","journal-title":"Hum Reprod"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"i381","DOI":"10.1093\/humrep\/33.Supplement_1.1","article-title":"Serum Amh as predictor of ovarian stimulation outcome among women undergoing oocyte cryopreservation prior to breast cancer treatment","volume":"33","author":"Wikander","year":"2018","journal-title":"Hum Reprod"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.fertnstert.2018.10.018","article-title":"Serum antim\u00fcllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation","volume":"111","author":"Sermondade","year":"2019","journal-title":"Fertil Steril"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/humrep\/deac109","article-title":"Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation","volume":"37","author":"Raad","year":"2022","journal-title":"Hum Reprod"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"15","DOI":"10.14660\/2385-0868-55","article-title":"Ovarian reserve biomarkers usefulness for optimization of counselling in a public network for fertility preservation in oncological patients","volume":"28","author":"Manno","year":"2016","journal-title":"Ital J Gynaecol Obstet"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10815-018-1377-0","article-title":"Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved","volume":"36","author":"Filippi","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1016\/j.fertnstert.2011.07.778","article-title":"The role of combined anti-mullerian hormone and antral follicle count assessment in predicting cycle outcomes in cancer patients undergoing controlled ovarian stimulation for fertility preservation","volume":"96","author":"Arslan","year":"2011","journal-title":"Fertil Steril"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2147\/IJWH.S373135","article-title":"Effect of surgical findings on prediction of postoperative ovarian reserve in patients with ovarian endometrioma","volume":"14","author":"Lee","year":"2022","journal-title":"Int J Womens Health"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13048-015-0209-4","article-title":"Age, anti-m\u00fcllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide","volume":"8","author":"D\u2019Avila","year":"2015","journal-title":"J Ovarian Res"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1016\/j.ejca.2013.07.014","article-title":"Pretreatment anti-m\u00fcllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer","volume":"49","author":"Anderson","year":"2013","journal-title":"Eur J Cancer"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejca.2017.10.001","article-title":"The utility of anti-M\u00fcllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer","volume":"87","author":"Anderson","year":"2017","journal-title":"Eur J Cancer"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1210\/jc.2010-2582","article-title":"Pretreatment serum anti-m\u00fcllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer","volume":"96","author":"Anderson","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.fertnstert.2021.08.034","article-title":"Ovarian transplantation with robotic surgery and a neovascularizing human extracellular matrix scaffold: a case series in comparison to meta-analytic data","volume":"117","author":"Oktay","year":"2022","journal-title":"Fertil Steril"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"i406","DOI":"10.1093\/humrep\/deac106.P-455","article-title":"Laparoscopic robot-assisted autologous transplantation of cryopreserved ovarian tissue: report of an operative technique and reproductive outcomes in a case series","volume":"37","author":"Fastrez","year":"2022","journal-title":"Hum Reprod"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1016\/j.fertnstert.2021.07.194","article-title":"Comparison of orthotopic (OA) and heterotopic (HA) autologous cryopreserved ovarian tissue transplantation (Acott) outcomes","volume":"116","author":"Oktay","year":"2021","journal-title":"Fertil Steril"},{"key":"ref146","first-page":"i61","article-title":"Improving autologous ovarian transplantation outcomes with robotic surgery and the utility of a neovascularizing human extra cellular matrix (ECM) scaffold","volume":"34","author":"Oktay","year":"2019","journal-title":"Hum Reprod"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/09513590.2019.1648413","article-title":"Heterotopic transplantation of cryopreserved ovarian tissue in cancer patients: a case series","volume":"35","author":"Bystrova","year":"2019","journal-title":"Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/27.s2.71","article-title":"Assessment of long-term endocrine function after transplantation of frozen-thawed human ovarian tissue to the heterotopic site: 10 year longitudinal follow-up study","volume":"27","author":"Kim","year":"2012","journal-title":"Hum Reprod"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1210\/jc.2010-2188","article-title":"Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment","volume":"96","author":"Janse","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"i66","DOI":"10.1093\/humrep\/de.25.s1.44","article-title":"Unexpected follicle dynamics after orthotopic and heterotopic ovarian tissue grafting\u2014experience from eight grafts","volume":"25","author":"Stern","year":"2019","journal-title":"Hum Reprod"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3205\/ctt-2009-No5-abstract29","article-title":"Restoration of ovarian function after cryopreserved ovarian tissue transplantation in women exposed to complex treatment for gynecological cancer: feasibility of this option in pediatric cancer patients","volume":"2","author":"Lisyanskya","year":"2009","journal-title":"Cell Ther Transplant"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.fertnstert.2008.04.019","article-title":"Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients","volume":"91","author":"Kim","year":"2009","journal-title":"Fertil Steril"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1016\/j.fertnstert.2022.08.575","article-title":"Is it safe to perform ovarian cryopreservation and transplantation in patients with leukemia a 5-year survival analysis data","volume":"118","author":"Sonmezer","year":"2022","journal-title":"Fertil Steril"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1093\/humrep\/deac104.036","article-title":"Safe and successful ovarian transplantations post leukemia after combined various MRD excluding tests","volume":"37","author":"Dereh Haim Tzfanya","year":"2022","journal-title":"Hum Reprod"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/humrep\/deaa353","article-title":"Ovarian tissue cryopreservation and transplantation in patients with central nervous system tumours","volume":"36","author":"Nguyen","year":"2021","journal-title":"Hum Reprod"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1111\/jog.14876","article-title":"The investigation of newly procedure to detect MRD using droplet digital PCR aiming safety ovarian tissue transplantation","volume":"47","author":"Kaoru","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s10815-020-01754-1","article-title":"Discordant results of minimal residual disease between cryopreserved cortex and medullar ovarian fragments collected in patients with acute leukemia in remission","volume":"37","author":"Florian","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/humrep\/dez115","article-title":"Dexamethasone does not prevent malignant cell reintroduction in leukemia patients undergoing ovarian transplant: risk assessment of leukemic cell transmission by a xenograft model","volume":"34","author":"D\u00edaz-Garc\u00eda","year":"2019","journal-title":"Hum Reprod"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3390\/cancers11111807","article-title":"Sensitive and specific detection of Ewing sarcoma minimal residual disease in ovarian and testicular tissues in an in vitro model","volume":"11","author":"Chaput","year":"2019","journal-title":"Cancers"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/humrep\/dex352","article-title":"Safety of ovarian tissue transplantation in patients with borderline ovarian tumors","volume":"33","author":"Masciangelo","year":"2018","journal-title":"Hum Reprod"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"i38","DOI":"10.1093\/humrep\/33.Supplement_1.1","article-title":"Potential leukaemic contamination in cryopreserved ovarian tissue","volume":"33","author":"Gook","year":"2018","journal-title":"Hum Reprod"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/bjh.14657","article-title":"Eliminating malignant cells from cryopreserved ovarian tissue is possible in leukaemia patients","volume":"178","author":"Soares","year":"2017","journal-title":"Br J Haematol"},{"key":"ref163","first-page":"i378","article-title":"Fertility preservation. Anatomopathological analysis of ovarian cortex metastasis in a large cohort of patient undergoing fertility preservation through ovarian cortex cryopreservation","volume":"32","author":"Garc\u00eda Camu\u00f1as","year":"2017","journal-title":"Hum Reprod"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"i326","DOI":"10.1016\/j.fertnstert.2016.04.031","article-title":"Transplantation of ovarian tissue in high risk patients treated for leukemia; safe approach resulting in ovulations, IVF cycles and pregnancy","volume":"31","author":"Meirow","year":"2016","journal-title":"Hum Reprod"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1093\/humrep\/dew193","article-title":"Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients","volume":"31","author":"Dolmans","year":"2016","journal-title":"Hum Reprod"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3109\/10428194.2015.1065980","article-title":"Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro","volume":"57","author":"Asadi-Azarbaijani","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.fertnstert.2015.08.009","article-title":"New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients","volume":"104","author":"Rodr\u00edguez-Iglesias","year":"2015","journal-title":"Fertil Steril"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.fertnstert.2014.11.001","article-title":"Searching for metastases in ovarian tissue before autotransplantation: a tailor-made approach","volume":"103","author":"Hoekman","year":"2015","journal-title":"Fertil Steril"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.fertnstert.2015.04.036","article-title":"Evaluation of quantitative polymerase chain reaction markers for the detection of breast cancer cells in ovarian tissue stored for fertility preservation","volume":"104","author":"Bockstaele","year":"2015","journal-title":"Fertil Steril"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"i251","DOI":"10.1093\/humrep\/det215","article-title":"Safety assessment of ovarian cryopreservation by molecular techniques in breast cancer patients","volume":"28","author":"Rodriguez-Iglesias","year":"2013","journal-title":"Hum Reprod"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.ejca.2013.01.032","article-title":"Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination","volume":"49","author":"Greve","year":"2013","journal-title":"Eur J Cancer"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/j.fertnstert.2012.07.454","article-title":"Ovarian tissue cryopreservation: analyzing ovarian tissue with different techniques to rule out micrometastases in patients with different kinds of primary tumors","volume":"98","author":"Hoekman","year":"2012","journal-title":"Fertil Steril"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.fertnstert.2010.12.019","article-title":"Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer","volume":"95","author":"Rosendahl","year":"2011","journal-title":"Fertil Steril"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.fertnstert.2009.11.032","article-title":"Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia","volume":"94","author":"Rosendahl","year":"2010","journal-title":"Fertil Steril"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1182\/blood-2010-01-265751","article-title":"Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe","volume":"116","author":"Dolmans","year":"2010","journal-title":"Blood"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/PGP.0b013e3181ad1c52","article-title":"Histologic evaluation of fresh human ovarian tissue before cryopreservation","volume":"29","author":"Azem","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1093\/humrep\/deq121","article-title":"Occasional involvement of the ovary in Ewing sarcoma","volume":"25","author":"Abir","year":"2010","journal-title":"Hum Reprod"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1093\/humrep\/dep196","article-title":"Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation","volume":"24","author":"S\u00e1nchez-Serrano","year":"2009","journal-title":"Hum Reprod"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/humrep\/den055","article-title":"Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients","volume":"23","author":"Meirow","year":"2008","journal-title":"Hum Reprod"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.rbmo.2023.03.004","article-title":"Evaluation of ovarian reserve in young females with non-iatrogenic ovarian insufficiency to establish criteria for ovarian tissue cryopreservation","volume":"47","author":"Zajicek","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"1135249","DOI":"10.3389\/fendo.2023.1135249","article-title":"Trends and outcomes of fertility preservation for girls, adolescents and young adults with turner syndrome: a prospective cohort study","volume":"14","author":"Rodriguez-Wallberg","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/14647273.2020.1794060","article-title":"Effectiveness of the flexible progestin primed ovarian stimulation protocol compared to the flexible GnRH antagonist protocol in women with decreased ovarian reserve","volume":"25","author":"Turkgeldi","year":"2022","journal-title":"Hum Fertil"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5653\/cerm.2020.03657","article-title":"Effect of a dual trigger on oocyte maturation in young women with decreased ovarian reserve for the purpose of elective oocyte cryopreservation","volume":"47","author":"Kim","year":"2020","journal-title":"Clin Exp Reprod Med"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3969\/j.issn.1672-1993.2019.09.020","article-title":"Clinical application of vitrification technique of oocytes in assisted reproduction","volume":"28","author":"Wang","year":"2019","journal-title":"Chin J. Hum Sex"},{"key":"ref185","first-page":"1361","article-title":"Hunan expert consensus on implementation plan of fertility preservation for young breast cancer patients","volume":"27","year":"2018","journal-title":"Chin J Gen Surg"},{"key":"ref186","first-page":"215","article-title":"Expert consensus on fertility-sparing treatment for early-stage endometrial cancer (2022)","volume":"24","year":"2022","journal-title":"Chin J Clin Obstet Gynecol"},{"key":"ref187","first-page":"673","article-title":"Chinese expert consensus on fertility-sparing surgery for early-stage cervical cancer","volume":"21","year":"2021","journal-title":"Chin J Minim Invasive Surg"},{"key":"ref188","first-page":"705","article-title":"Chinese expert consensus on fertility preservation in malignant ovarian tumors (2022)","volume":"38","year":"2022","journal-title":"Chin J Pract Gynecol Obstet"},{"key":"ref189","first-page":"113","article-title":"Chinese expert consensus on clinical practice of fertility preservation in lymphoma patients","volume":"43","year":"2023","journal-title":"Chin J Reprod Contracep"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn","year":"2012","journal-title":"J Gen Intern Med"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"CD001431","DOI":"10.1002\/14651858.CD001431.pub5","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1730617\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:29:23Z","timestamp":1771925363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1730617\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":191,"alternative-id":["10.3389\/fmed.2025.1730617"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1730617","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"article-number":"1730617"}}